MedTrace Logo

Collection of Samples USOPTIVAL Study

NCT04792684 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 1300

Last updated 2025-11-10

No results posted yet for this study

Summary

A prospective multi-center observational study. The study will enroll eligible subjects from the United States to optimize the biomarker panel and evaluate the performance of a cfDNA marker panel selected by the Sponsor for CRC and advanced adenoma detection.

Conditions

  • Colorectal Cancer (CRC)
  • Advanced Adenomas (AA)

Interventions

DIAGNOSTIC_TEST

Optimization of Plasma Circulating Free-DNA (cfDNA) Marker Panel

Evaluate the performance of a preliminary panel of biomarkers

Sponsors & Collaborators

  • Universal Diagnostics

    lead INDUSTRY

Eligibility

Min Age
45 Years
Max Age
84 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-12-30
Primary Completion
2025-12-30
Completion
2025-12-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04792684 on ClinicalTrials.gov